Jefferies initiated coverage of Acuren (TIC) with a Buy rating and $16 price target The company is positioned to boost EBITDA margins due to cost synergies from the NV5 acquisition, operating leverage, and business improvements, the analyst tells investors in a research note. The firm views Acuren’s $20M NV5 cost synergy target as conservative.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TIC: